Artificial intelligence is quietly reshaping the pharmaceutical industry and the financial upside could be enormous.

Artificial intelligence is accelerating drug development and lowering costs across the pharmaceutical industry, potentially boosting operating profits by more than 10%, according to Bernstein.

AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

SAN FRANCISCO (KRON) – As the use of artificial intelligence becomes a more popular tool in drug research, a scientific software company aims to one day use the technology to predict future medicines.

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

Illustration showing how integrating protein three-dimensional structures with artificial intelligence algorithms can predict synergistic or antagonistic effects of drug combinations, guiding safer ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...